FAKTOR-OPTIONSSCHEIN - GETINGE B Share Price

Certificat

DE000MG14E32

Delayed Börse Stuttgart 07:41:54 20/05/2024 pm IST
6.09 EUR +1.84% Intraday chart for FAKTOR-OPTIONSSCHEIN - GETINGE B
Current month-56.32%
1 month-41.08%
Date Price Change
20/24/20 6.09 +1.84%
17/24/17 5.98 -8.42%
16/24/16 6.53 -2.39%
15/24/15 6.69 -33.17%
14/24/14 10.01 +7.87%

Delayed Quote Börse Stuttgart

Last update May 20, 2024 at 07:41 pm IST

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying GETINGE AB
Issuer Morgan Stanley
WKN MG14E3
ISINDE000MG14E32
Date issued 27/03/2024
Strike 123.8 kr
Maturity Unlimited
Parity 0.89 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 14.29
Lowest since issue 5.98
Spread 0.04
Spread %0.66%

Company Profile

Getinge AB is the world's leader in producing and marketing medical equipment intended to health care facilities (clinics, hospitals, rest homes, etc.). Net sales break down by family of products as follows: - medical systems (57.4%): equipment for operating rooms (primarily tables and lighting systems), ventilators and heart and lung machines, etc.; - hospital sterilization equipment (29.4%); - contamination prevention equipment (13.2%): in the fields of biopharmaceutical production, biomedical research, manufacturing of medical devices and laboratory applications. Net sales break down by source of income into sales of equipment (45.3%), consumables (37.1%), services and spare parts (17.6%). At the end of 2021, the group had 20 production sites worldwide. Net sales are distributed geographically as follows: Sweden (1.8%), Europe/Middle East/Africa (35.8%), Americas (37.9%) and Asia/Pacific (24.5%).
Sector
-
More about the company

Ratings for Getinge AB

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Getinge AB

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
185.5 SEK
Average target price
229.2 SEK
Spread / Average Target
+23.57%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW